RECENT ADVANCEMENTS IN THE MANAGEMENT OF MULTI DRUG RESISTANT TUBERCULOSIS (MDR TB)

Multidrug-resistant tuberculosis (MDR-TB) is an increasing global problem, with most cases arising from a blend of physician error and patient non-cooperation during treatment of susceptible TB. The extent and burden of MDR-TB varies significantly from country to country and region to region. There are many drugs available to treat tuberculosis like first line drugs and second line drugs. Even though the number of TB case is increasing day by day. This review is dealing with the FDA approved drugs and drugs under study.\n\nKey Words: TB, MDR TB, First line drugs, Second line drugs, FDA approved drugs, drugs under study